Cover Image

Imatinib and beyond - the new CML study IV: A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia

Saved in:
Bibliographic Details
Main Authors: Berger, Ute (Author) , Engelich, G. (Author) , Reiter, Andreas (Author) , Hochhaus, Andreas (Author) , Hehlmann, Rüdiger (Author)
Format: Article (Journal)
Language:English
Published: 2004
In: Annals of hematology
Year: 2004, Volume: 83, Issue: 4, Pages: 258-264
ISSN:1432-0584
DOI:10.1007/s00277-003-0807-x
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00277-003-0807-x
Get full text
Author Notes:U. Berger, G. Engelich, A. Reiter, A. Hochhaus, R. Hehlmann, The German CML Study Group
Description
Item Description:Published: 29 November 2003
Gesehen am 12.05.2022
Physical Description:Online Resource
ISSN:1432-0584
DOI:10.1007/s00277-003-0807-x

Similar Items